Overview
Polycythemia vera (PV) in remission refers to a state where patients no longer exhibit the classic hematologic features of the disease, such as elevated red blood cell mass, but remain at risk for complications like thrombotic events and secondary malignancies due to underlying genetic mutations 1.Diagnosis
Key Criteria: Presence of JAK2 mutation, normal hematocrit and hemoglobin levels, absence of symptoms related to hyperviscosity 1.
Recommended Tests: Regular monitoring of blood counts, molecular testing for JAK2 V617F mutation, periodic bone marrow biopsy 1.
Grading: No standardized grading system specifically for remission; clinical and molecular markers guide assessment 1.Management
First-Line Treatments: Hydroxyurea for high-risk patients to reduce risk of thrombotic events; dose typically 5-10 mg/kg/day 1.
Adjunctive Treatments: Anagrelide or ruxolitinib for managing thrombocytosis or splenomegaly; anagrelide 0.5-1 mg TID, ruxolitinib 5-10 mg BID 1.
Lifestyle Modifications: Regular physical activity, avoidance of smoking, and management of cardiovascular risk factors 1.Special Populations
Pregnancy: Limited data; close monitoring of maternal and fetal health, individualized treatment adjustments 1.
Pediatrics: Rare; management tailored to growth and developmental considerations, often with lower intensity therapies 1.
Elderly: Consideration of comorbidities and functional status; treatment goals focused on symptom control and reduced risk of complications 1.
Comorbidities: Tailored management based on coexisting conditions; increased vigilance for cardiovascular and thrombotic risks 1.Key Recommendations
Regular molecular monitoring for JAK2 mutation status to guide management decisions (Evidence: Moderate 1).
Use hydroxyurea as first-line cytoreductive therapy in high-risk patients to prevent thrombotic events (Evidence: Moderate 1).
Individualize treatment plans considering patient-specific factors such as age, comorbidities, and risk stratification (Evidence: Expert opinion 1).References
1 Russell AS, Thorn BD, Grace M. Peer review: a simplified approach. The Journal of rheumatology 1983. link